Medtronic is the world leader in medical technology providing lifelong solutions for people with chronic disease. We offer products, therapies and services that enhance or extend the lives of millions of people. Each year, 5 million patients benefit from Medtronic's technology, used to treat conditions such as diabetes, heart disease, neurological disorders, and vascular illnesses.
710 Medtronic Pkwy
Minneapolis, MN 55432-5604
News | Stents Drug Eluting | November 02, 2016
Independent Study Finds Biodegradable Polymer Stents Provide No Clinical Benefit Over Resolute Integrity DES
Investigators recently unveiled clinical data from the independent BIO-RESORT study, representing the first all-comers...
News | Heart Valve Technology | November 02, 2016
Medtronic Harmony Transcatheter Pulmonary Valve Demonstrates Positive Early Clinical Outcomes at One Year
Medtronic plc recently announced new clinical data for the Harmony Transcatheter Pulmonary Valve (TPV) from its early...
News | Stents Drug Eluting | November 01, 2016
November 1, 2016 — Medtronic plc unveiled the first clinical outcomes of its novel...
News | Heart Valve Technology | October 31, 2016
Medtronic plc presented new positive data from two large registries aimed at evaluating 30-day clinical performance...
Technology | Heart Valve Technology | October 26, 2016
Medtronic announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the CoreValve Evolut R 34...
Technology | Atherectomy Devices | October 24, 2016
October 24, 2016 — Medtronic received U.S.
News | Cath Lab | October 18, 2016
Medtronic plc announced last week that it has notified customers of a voluntary recall of certain lots of its Pipeline...
News | Ablation Systems | October 17, 2016
Medtronic plc last week unveiled new health economic analysis data from the FIRE AND ICE trial that favor cryoballoon...
Technology | EP Lab | October 13, 2016
Medtronic plc is the first company to receive U.S. Food and Drug Administration (FDA) approval for its suite of cardiac...
News | Cath Lab | October 12, 2016
VIVA (Vascular Interventional Advances) Physicians announced a number of highly anticipated late-breaking clinical...